TY - JOUR
T1 - Optimizing treatment for men with advanced prostate cancer
T2 - Expert recommendations and the multidisciplinary approach
AU - Fitzpatrick, John M.
AU - Anderson, John
AU - Sternberg, Cora N.
AU - Fleshner, Neil
AU - Fizazi, Karim
AU - Rébillard, Xavier
AU - Dogliotti, Luigi
AU - Conti, Giario
AU - Turesson, Ingela
AU - James, Nicholas
AU - Heidenreich, Axel
AU - Solsona, Eduardo
AU - Guillem, Vicente
AU - Herchenhorn, Daniel
AU - Moul, Judd
AU - van Moorselaar, Jeroen
AU - Coetzee, Lance J.E.
AU - Wilson, Andrew
AU - Bamias, Aristotelis
AU - De Wit, Ronald
AU - Chrisofos, Michael
PY - 2008/10/1
Y1 - 2008/10/1
N2 - A multidisciplinary panel of 20 international experts, including urologists, radiation oncologists, and medical oncologists, convened during the Advanced Prostate Cancer Multidisciplinary Team meeting in Rome, Italy, in January 2007, to discuss the multidisciplinary team approach and current patterns of care for patients with hormone-refractory prostate cancer (HRPC). During the meeting, the experts discussed several definitions currently used in prostate cancer management, including those for senior adult patients. In addition, the panel reviewed a series of patient case studies in order to provide feedback on current treatment practices and to identify possible strategies for best practice. It was stressed that treatment decisions for senior adult patients should not be based solely on patient age. Additionally, although historically treatment decisions for advanced prostate cancer have focused on palliative care, given the survival benefit associated with docetaxel-based chemotherapy across patient subgroups, more men are likely to be offered chemotherapy for advanced-stage disease in the future.
AB - A multidisciplinary panel of 20 international experts, including urologists, radiation oncologists, and medical oncologists, convened during the Advanced Prostate Cancer Multidisciplinary Team meeting in Rome, Italy, in January 2007, to discuss the multidisciplinary team approach and current patterns of care for patients with hormone-refractory prostate cancer (HRPC). During the meeting, the experts discussed several definitions currently used in prostate cancer management, including those for senior adult patients. In addition, the panel reviewed a series of patient case studies in order to provide feedback on current treatment practices and to identify possible strategies for best practice. It was stressed that treatment decisions for senior adult patients should not be based solely on patient age. Additionally, although historically treatment decisions for advanced prostate cancer have focused on palliative care, given the survival benefit associated with docetaxel-based chemotherapy across patient subgroups, more men are likely to be offered chemotherapy for advanced-stage disease in the future.
KW - Case study
KW - Docetaxel
KW - Hormone-refractory prostate cancer
KW - International society of geriatric oncology (SIOG)
KW - Multidisciplinary
KW - Senior adult patients
UR - http://www.scopus.com/inward/record.url?scp=50449085844&partnerID=8YFLogxK
U2 - 10.1016/j.critrevonc.2008.07.019
DO - 10.1016/j.critrevonc.2008.07.019
M3 - Review article
C2 - 18723368
AN - SCOPUS:50449085844
SN - 1040-8428
VL - 68
SP - S9-S22
JO - Critical Reviews in Oncology/Hematology
JF - Critical Reviews in Oncology/Hematology
IS - 1 SUPPL.
ER -